News


Streck Adds Roche Instrument to HbA1c Control Assay

The A1c-Cellular®, an HbA1c control with intact red blood cells from Streck, Omaha, Neb, is now assayed for Roche cobas® c 311.

A1c-Cellular tests the entire HbA1c procedure, including the lysing of the red blood cells.

A1c-CellularThis important step ensures the entire system–instrument and reagents–is working properly and providing accurate patient results. The control is easy to use; it does not require reconstitution, which reduces the potential for human error.

The control is appropriate for immunoassay and ionic exchange HPLC methodologies.

It is also assayed for the Abbott ARCHITECT® c Systems; Arkray Menarini ADAMS™ A1c HA-8160; Beckman Coulter® UniCel® DxC 600/800 Synchron®; Bio-Rad® D10/Variant II™/Variant II Turbo; Ortho-Clinical Diagnostics VITROS® 5, 1 FS/VITROS 5600; Roche cobas Integra®/cobas 6000; Siemens Healthcare Diagnostics Inc Dimension Series; and the Tosoh A1c 2.2 Plus/G7/G8.

Available in 2.0ml plastic screw-top, cap-pierceable vials, the control offers a closed-vial stability of 6 months and an open-vial stability of 30 days.

[Source: Streck]